Dr. Robert Quinn
SUNY Upstate Medical
University of Syracuse.
USA
As the lifespan of humans has lengthened, neurodegenerative diseases have had more of an impact on quality of life as previously they may not have expressed prior to death from other health conditions. As these diseases become “more prevalent”, research into both the underlying pathological processes and potential therapies becomes increasingly important. This presentation will focus on the most current animal models in use to for research into such diseases as Huntington’s Disease, Alzheimer’s Disease, Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS). Establishing animal models of human neurological diseases (especially those with cognitive and behavioral components) can be challenging. We will examine both the positive attributes of these models for representing the human disease as well as their limitations.
